Scientific Program

Scientific Program

Friday, March 29, 2019

10:00 -17:00

Registration & Distribution of Materials

14:00

Opening Remarks

Ian A. Greer, UK; Benjamin Brenner, Israel; Manuel Monreal, Spain

14:10-15:45

 

SESSION 1: Cancer and Thrombosis in Women

Chairs:      David Jiménez, Spain 

                   Zoubida Tazi Mezalek, Morocco

14:10

Novel endothelial mechanisms of venous thrombosis

Katrin Schäfer, Germany

14:35

Chemotherapy-induced vascular toxicity

Irit Ben-Aharon, Israel

15:00

Risk assessment of cancer-associated thrombosis: How to stratify right and to treat right

Ismail Elalamy, France

15:25

Selected Oral Communications

  • Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome: The NOHA-K observational study

J-C. Gris, E. Mousty, S. Bouvier, S. Ripart, E. Cochery-Nouvellon, E. Mercier, J. Broner, V. Letouzey, A. Perez-Martin, France

  • Clinical utility of a simple risk assessment model for cancer-associated thrombosis to identify breast cancer patients at high risk of symptomatic central venous catheter-related thrombosis

C. Frere, M. Espié, J. Gligorov, A. Elias, P.F. Dupré, S. Villiers, S. Giacchetti, P. Debourdeau, D. Farge, France

15:45-16:15

C O F F E E   B R E A K

16:15-17:30

SESSION 2: Peri-partum and Neonatal Complications

Chairs:      Ismail Elalamy, France

                  Emmanouil Papadakis, Greece

16:15

Pathogenesis of neonatal thrombosis: New insights

Gili Kenet, Israel

16:40

The role of hemostasis in placenta-mediated complications

Jean-Christophe Gris, France

17:05

Selected Oral Communications

  • Safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation (DIC)

T. Kobayashi, M. Kajiki, K. Nihashi, G. Honda, Japan

  • Stillbirth and Factor V Leiden - a regional based prospective evaluation

I. Björk, K. Pettersson , P.G. Lindqvist, Sweden

17:30-18:30

SANOFI Satellite Symposium

Thrombosis and pregnancy – the current state of the art

17:30

Welcome and Introduction

Benjamin Brenner, Israel

17:35

VTE prophylaxis during pregnancy and puerperium

Anne Flem Jacobsen, Norway

17:50

Treatment of established VTE in pregnancy

Grégoire Le Gal, Canada

18:05

Challenges in peripartum management of thrombosis

Jean Christophe Gris, France

18:20

Q & A

18:30

Conclusion and take-home messages

Benjamin Brenner, Israel

20:00-22:00

GET TOGETHER RECEPTION

Saturday, March 30, 2019

08:30-10:25

SESSION 3: Coagulation in Women

Chairs:     Menno V. Huismann, the Netherlands

                  Ida Martinelli, Italy

08:30

Hemostasis during extreme exertion

Bas de Laat, the Netherlands

08:55

Hormonal contraceptive use after the diagnosis of an acute VTE event

Frederikus A. Klok, the Netherlands

09:20

DOACS in women: Pros and cons

Jan Beyer-Westendorf, Germany

09:45

Selected Oral Communications

  • Prevalence of cerebral venous thrombosis with the use of oral contraceptive at a tertiary hospital

M. Alsheef, A. AlShamrani, A. AlHamidi, M. AlOtaibi, N. AlAnazi, S. AlHathlool, O. AlArfaj, A. AlBoghdadly, Saudi Arabia

  • IDO activity forecasts obesity in females in 10-year follow-up study: the Cardiovascular Risk in Young Finns Study

      P.Niinisalo, OT.Raitakari, M.Kähönen, J.Viikari, M. Juonala, R.Kaaja, Finland

  • Type of combined contraceptives and the risk of venous thromboembolism in antithrombin, protein C and protein s deficient women. A prospective cohort study
    D.Tormene, S. Gavasso,  P. Zerbinati, M. Fadin, P. Simioni, Italy
  • Vena caval filter in pregnant women with acute venous thromboembolism. Is it useful and safe?

V. Salazar, A. Castillo, A. Rivas, R. Valle, J. A. Nieto, C. Font, S. Schellong, A. Braester, Á. Fidalgo, M.Monreal, Spain

 

10:25-10:55

C O F F E E   B R E A K

10:55-12:30

SESSION 4: Venous Thromboembolism in Women

Chairs:      Grégoire Le Gal, Canada

                   Manuel Monreal, Spain

10:55

Advances in the diagnosis of venous thromboembolism in pregnancy

Menno V. Huisman, the Netherlands

11:20

Risk-adapted management of pulmonary embolism in women

David Jiménez, Spain

11:45

Pregnancy after cerebral venous thrombosis

Ida Martinelli, Italy

12:10

Selected Oral Communications

  • A systematic review and meta-analysis of incidence of venous thromboembolism in pregnancy   

J. Daru, A. Asour, F. E. T. Shiers-Gelalis, E. Oliver, F. Aktar, E. Rogozinska, B. Hunt, S. Thangaratinam, UK

  • Difficult decisions: Anticoagulation choice during pregnancy in patients with mechanical heart valves (MHVs)

R. Halabi, H. Parry, P. Owegie, K.M. English, J.J. Oliver, E. Horn, E. Ciantar, UK

12:30-14:00

ROVI Laboratories – Lunch Satellite Symposium

Role of LMWH for VTE management in women's health

Chairperson: Benjamin Brenner, Israel

13:00

VTE burden in women's health

Benjamin Brenner, Israel

13:15

Thromboprophylaxis after gynecological surgeries

Shahla Alalah, Iraq

13:35

Do low molecular weight heparins improve pregnancy outcomes?

Johnny Awwad, Lebanon

13:55

Discussion & Closing

14:00-15:35

SESSION 5: Pregnancy Complications

Chairs:      Anne Flem Jacobsen, Norway

                   Armando D'Angelo, Italy

14:00

Managing antiphospholipid syndrome in pregnancy

Beverly Hunt, UK

14:25

Pregnancy outcomes in women with mechanical prosthetic heart valves

Roopen Arya, UK

14:50

Prevention and treatment of postpartum hemorrhage – Lessons from large trials

Haleema Shakur-Still, UK

15:15

Selected Oral Communications

  • Thrombomodulin regulates platelet and extracellular vesicle mediated sterile inflammation in the placenta

S. Kohli, Shrey Kohli, P. Markmeyer, F. Lochmann, MM. Al-Dabet, S. Ranjan, B. Isermann, Germany

  • Safety and effectiveness of enoxaparin in pregnancy: A systematic review and meta-analysis

B. Jacobson, V. Rambiritch, T. Sayre, P. Naidoo, J. Shan, R. Leisegang, South Africa

15:35-17:00

POSTER DISCUSSION SESSION & C O F F E E   B R E A K

Moderators:

  • Rezan Abdul Kadir, UK
  • Jacob Rand, USA
  • Paolo Simioni, Italy

17:45-21:00

GALA DINNER (optional)

 

 

Sunday, March 31, 2019

09:00-10:40

SESSION 6: From Big Data to Precision Medicine

Chairs:      Ian A. Greer, UK

                  Benjamin Brenner, Israel

09:00

 

Current ISTH registries on women's issues in thrombosis and hemostasis

Maha Othman, Canada

09:25

International guidelines and personalized medicine

Dominique Farge-Bancel, France

09:50

International registries: Implications of real-life data

Manuel Monreal, Spain

10:15

Precision medicine: A new dawn for health research from system integration to maternal medicine?

Ian A. Greer, UK

10:40-11:10

C O F F E E   B R E A K

11:10-12:45

SESSION 7: Bleeding Disorders

Chairs:     Gili Kenet, Israel

                 Roopen Arya, UK

11:10

Inherited platelet disorders in women

Paolo Gresele, Italy

11:35

Antidepressants: Bleeding or thrombosis?

Silvia Hoirisch-Clapauch, Brazil

12:00

Novel therapies for Factor VIII inhibitors

Riitta Lassila, Finland

12:25

Selected Oral Communications

  • Congenital FX deficiency in women: A systematic review of the literature D. Spiliopoulos, D. Obeng-Tuudah, R.A. Kadir, UK
  • Predictors of effective radiation dose for CT pulmonary angiography in pregnancy across a large health system S. Cohen, J. Wang, N. Chan, W. O’Connell, A. McCandlish, C. Feizullayeva, P. Sanelli, USA   

12:45-13:00

Concluding Remarks –

an A. Greer, UK; Benjamin Brenner, Israel; Manuel Monreal, Spain

13:00-14:00

L U N C H

 


Related Documents